CAPTRUST Financial Advisors
APTO

CAPTRUST Financial Advisors’s Aptose Biosciences, Inc. APTO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4
Closed -$1K – 4449
2022
Q2 		$1K Hold
4
– – ﹤0.01% 4816
2022
Q1 		$3K Sell
4
-10
-71% -$5.53K ﹤0.01% 4418
2021
Q4 		$9K Hold
14
– – ﹤0.01% 3809
2021
Q3 		$14K Hold
14
– – ﹤0.01% 3420
2021
Q2 		$21K Hold
14
– – ﹤0.01% 3087
2021
Q1 		$38K Hold
14
– – ﹤0.01% 2614
2020
Q4 		$28K Hold
14
– – ﹤0.01% 2105
2020
Q3 		$40K Sell
14
-2
-13% -$4.99K ﹤0.01% 1719
2020
Q2 		$46K Buy
+16
New +$51.6K ﹤0.01% 1654
2020
Q1 		– Sell
-24
Closed -$61K – 1436
2019
Q4 		$61K Buy
+24
New +$31.3K ﹤0.01% 1000

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return

CAPTRUST Financial Advisors's APTO Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Aptose Biosciences, Inc. (APTO) in Q3 2022, closing a stake of 4 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in APTO in Q4 2019 and held it in 10 quarters. The position peaked at $61K in Q4 2019. 49 funds tracked by Wall St. Rank hold APTO as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Aptose Biosciences, Inc. position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 4 Aptose Biosciences, Inc. shares in Q3 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in Aptose Biosciences, Inc. in Q4 2019 and held it in 10 quarters.
  • CAPTRUST Financial Advisors's Aptose Biosciences, Inc. position peaked at $61K in Q4 2019.
  • 49 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.